Let’s Reach Your Development Milestones Together

Gareth Sexton

Manager, Business Development

 

Bio for Gareth

Analytical Solutions from Research to Market

Group Created with Sketch.
Research
Preclinical
Group 2 Created with Sketch.

Discovery – Pre-clinical

Biologic Candidate Evaluation, Optimization and Selection into IND

Group 3 Created with Sketch.
Phase I
Phase II
Phase III
Group 4 Created with Sketch.

Phase I – Phase III

Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA

Group Created with Sketch.
Registration
Market
Group 2 Created with Sketch.

Registration – Market

Commercial-Stage Comparability Testing by Qualified Advanced Methods

Biologic Therapeutics
Platform Expertise

  • bullet Created with Sketch.

    mAbs

  • bullet Created with Sketch.

    Bispecifics/Multispecifics

  • bullet Created with Sketch.

    Recombinant Proteins—Including Complex, Highly Glycosylated Proteins

  • bullet Created with Sketch.

    Multi-subunit Complexes—Protein, Nucleotide, Ligand

  • bullet Created with Sketch.

    Fusion Proteins

  • bullet Created with Sketch.

    Enzyme Replacement Therapies

  • bullet Created with Sketch.

    ADCs and Protein Conjugates

  • bullet Created with Sketch.

    PEGylated Proteins

  • bullet Created with Sketch.

    Biosimilars

  • bullet Created with Sketch.

    Vaccines, Including Subunit/Recombinant

Cell and Gene Therapeutic Platform Expertise

  • bullet Created with Sketch.

    Capsid-based Vectors

  • bullet Created with Sketch.

    Complex, Envelope Vectors

  • bullet Created with Sketch.

    Non-viral Vectors

  • bullet Created with Sketch.

    Genetic Engineering